Substance Abuse Treatment, Prevention, and Policy Treatment of Alcohol Dependence in Patients with Co-morbid Major Depressive Disorder – Predictors for the Outcomes with Memantine and Escitalopram Medication

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Age at onset of first depressive episode as a predictor for escitalopram treatment of major depression comorbid with alcohol dependence.

  2009cited by this paper
• Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.

  2008cited by this paper
• Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients.

  2007cited by this paper
• Which antidepressants have demonstrated superior efficacy? A review of the evidence

  2007cited by this paper
• A pilot double-blind treatment trial of memantine for alcohol dependence.

  2007cited by this paper
• Choosing the right medication for the treatment of alcoholism

  2006cited by this paper
• Effectiveness of structured questionnaires for screening heavy drinking in middle-aged women.

  2006cited by this paper
• Managing depressive and anxiety disorders with escitalopram

  2006cited by this paper
• Recovery from DSM-IV Alcohol Dependence: United States, 2001-2002

  2006cited by this paper
• New pharmacological approaches for the treatment of alcoholism

  2006cited by this paper
• Behavioral effects of aminoadamantane class NMDA receptor antagonists on schedule-induced alcohol and self-administration of water in mice

  2006cited by this paper
• A double-blind, placebo-controlled study of memantine in the treatment of major depression.

  2006cited by this paper
• The Effects of Acamprosate and Neramexane on Cue-Induced Reinstatement of Ethanol-Seeking Behavior in Rat

  2005cited by this paper
• Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• Neuroprotective and Abstinence-Promoting Effects of Acamprosate

  2005cited by this paper
• Pharmacological Relapse Prevention of Alcoholism: Clinical Predictors of Outcome

  2005cited by this paper
• Role of the Serotonergic System in the Neurobiology of Alcoholism

  2004cited by this paper
• Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.

  2004cited by this paper
• Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology.

  2004cited by this paper
• Acute effects of memantine in combination with alcohol in moderate drinkers

  2004cited by this paper
• Treatment of alcohol abuse: an evidence-based review.

  2003cited by this paper
• Alcohol and psychiatric comorbidity.

  2003cited by this paper
• A 60-year follow-up of alcoholic men.

  2003cited by this paper
• Anxiety as a predictor of relapse in detoxified alcohol-dependent patients.

  2002cited by this paper
• Audit-3 and audit-4: effectiveness of two short forms of the alcohol use disorders identification test.

  2002cited by this paper
• The role of selective serotonin reuptake inhibitors in reducing alcohol consumption.

  2001cited by this paper
• Double-Blind Clinical Trial of Sertraline Treatment for Alcohol Dependence

  2001cited by this paper
• Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.

  2001cited by this paper
• Targeted Use of Naltrexone Without Prior Detoxification in the Treatment of Alcohol Dependence: A Factorial Double-Blind, Placebo-Controlled Trial

  2001cited by this paper
• The European acamprosate trials: conclusions for research and therapy.

  2001cited by this paper
• Obsessive-compulsive aspects of craving: development of the Obsessive Compulsive Drinking Scale.

  2000cited by this paper
• Recent Animal Models of Alcoholism

  2000cited by this paper
• A three-pathway psychobiological model of craving for alcohol.

  1999cited by this paper
• Fluoxetine versus placebo in depressed alcoholic cocaine abusers.

  1998cited by this paper
• ETHANOL‐REINFORCED BEHAVIOUR IN THE RAT: EFFECTS OF THE UNCOMPETITIVE NMDA RECEPTOR ANTAGONIST, MEMANTINE

  1998cited by this paper
• Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial.

  1997cited by this paper
• Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey.

  1997cited by this paper
• Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics.

  1996cited by this paper
• Citalopram in the treatment of alcoholism: a double-blind placebo-controlled study.

  1996cited by this paper
• Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.

  1993cited by this paper
• Evaluation of the Effects of Serotonin Uptake Inhibitors in Alcoholics: A Review

  1992cited by this paper
• Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study.

  1992cited by this paper
• Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity.

  1992cited by this paper
• Serotonin in early onset, male alcoholics with violent behaviour.

  1990cited by this paper
• Genetic heterogeneity and the classification of alcoholism.

  1988cited by this paper
• Psychopathology as a predictor of treatment outcome in alcoholics.

  1987cited by this paper
• A systematic method for clinical description and classification of personality variants. A proposal.

  1987cited by this paper
• Modulation of ethanol intake by serotonin uptake inhibitors.

  1986cited by this paper
• Zimeldine: a review of its effects on ethanol consumption.

  1984cited by this paper
• Diary gives more accurate information about alcohol consumption than questionnaire.

  1983cited by this paper

• Off-Label Medications and Non-Invasive Brain Stimulation (NIBS) in the Treatment of Internet Gaming Disorder: A Systematic Review and Meta-Analysis.

  2026cites this paper
• Navigating the challenges of substance use and psychopathology in depression, bipolar disorder, and schizophrenia.

  2025cites this paper
• Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis

  2022cites this paper
• Symptoms of Protracted Alcohol Withdrawal in Patients with Alcohol Use Disorder: A Comprehensive Systematic Review

  2022influential citation
• Mechanistic insights into the efficacy of memantine in treating certain drug addictions.

  2021cites this paper
• Randomized trial to assess safety/feasibility of memantine administration during residential treatment for alcohol use disorder: a pilot study

  2020cites this paper
• A novel NMDA receptor-based intervention to suppress compulsion-like alcohol drinking.

  2019cites this paper
• Pharmacotherapeutic options for co-morbid depression and alcohol dependence

  2019influential citation
• Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.

  2018cites this paper
• Pharmacological treatment for dual diagnosis: a literature update and a proposal of intervention

  2018cites this paper
• Comorbidity of Alcohol Use Disorder and Depression: A Case Report and Review of the Literature

  2017cites this paper
• What is the mechanism of Ketamine's rapid‐onset antidepressant effect? A concise overview of the surprisingly large number of possibilities

  2017cites this paper
• Do specific NMDA receptor subunits act as gateways for addictive behaviors?

  2017cites this paper
• Combined Effects of Acamprosate and Escitalopram on Ethanol Consumption in Mice.

  2016cites this paper
• Antidepressant and molecular responses to ketamine linked to its inhibition of glycogen synthase kinase-3 (GSK3)

  2016cites this paper
• Experience sampling and ecological momentary assessment studies in psychopharmacology: A systematic review.

  2015cites this paper
• Prescription for antidepressant in reducing future alcohol-related readmission in patients suffering from depression and alcohol use disorder: a retrospective medical record review

  2015cites this paper
• Pharmacotherapy of Dual Disorders

  2015cites this paper
• Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial.

  2015cites this paper
• Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.

  2014cites this paper
• Administration of memantine during withdrawal mitigates overactivity and spatial learning impairments associated with neonatal alcohol exposure in rats.

  2014cites this paper
• Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

  2014cites this paper
• Improvement of a Woman’s Alcohol-Related Dementia via Off-label Memantine Treatment

  2014cites this paper
• A 10-Week Memantine Treatment in Bipolar Depression: A Case Report. Focus on Depressive Symptomatology, Cognitive Parameters and Quality of Life

  2013cites this paper
• Is methoxydine a new rapid acting antidepressant for the treatment of depression in alcoholics?

  2013cites this paper
• A randomized, controlled, pilot study of acamprosate added to escitalopram in adults with major depressive disorder and alcohol use disorder.

  2012cites this paper
• The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias

  2012cites this paper
• BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

  2012cites this paper
• Citalopram versus other anti-depressive agents for depression.

  2012cites this paper
• The Canadian Network for Mood and Anxiety Treatments (Canmat) Task Force Recommendations for the Management of Patients with Mood Disorders and Comorbid Substance Use Disorders

  2012cites this paper
• Bağimlilik Psikofarmakolojisi Psychopharmacology of Addiction

  2012cites this paper
• Serotonin transporter polymorphism as a predictor for escitalopram treatment of major depressive disorder comorbid with alcohol dependence.

  2011cites this paper
• Memantyna w leczeniu zaburzeń afektywnych

  2011cites this paper
• Dual Diagnosis: Focusing on Depression and Recommendations for Treatment

  2011cites this paper
• Pharmacologic dissociation between impulsivity and alcohol drinking in high alcohol preferring mice.

  2010cites this paper
• Pharmacotherapy for Alcoholism and Some Related Psychiatric and Addictive Disorders: Scientific Basis and Clinical Findings

  2010cites this paper
• Why do some promising brain-stimulation devices fail the next steps of clinical development?

  2010cites this paper
• Komorbidität von Abhängigkeits-erkrankungen, affektiven Störungen und Angststörungen

  2009cites this paper
• Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias

  2009cites this paper
• Treatment of patients comorbid with alcohol dependence and major depressive disorder with memantine and escitalopram - outcome and predictors

  2008cites this paper
• Clinical Interventions in Aging Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Memantine: a Review of Studies into Its Safety and Efficacy in Treating Alzheimer's Disease and Other Dementias

  year unknowncites this paper